Human brucellosis in Kenya.
The serology, epidemiologic features and clinical presentation of 39 patients suffering from Brucellosis in Kenya are described. The prevalent species was Brucella melitensis. There was a striking preference in the localisation of the infection for the spine and the hip joint. The disease runs a protracted course. Phenomena due to hypersensitivity and neuropsychiatric disorders are discussed. Advice regarding specific treatment is given.
D000328:Adult; D002002:Brucella / Q000302:isolation & purification; D002006:Brucellosis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D002648:Child; D004318:Doxycycline / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007592:Joint Diseases / Q000209:etiology; D007630:Kenya; D008297:Male; D012698:Serologic Tests; D013122:Spinal Diseases / Q000209:etiology; D013307:Streptomycin / Q000008:administration & dosage; D013411:Sulfadiazine / Q000008:administration & dosage; D013420:Sulfamethoxazole / Q000008:administration & dosage; D013752:Tetracycline / Q000008:administration & dosage; D014295:Trimethoprim / Q000008:administration & dosage
D013411:Sulfadiazine; D014295:Trimethoprim; D013752:Tetracycline; D013420:Sulfamethoxazole; D004318:Doxycycline; D013307:Streptomycin